Black Service Does it Again. ANPI gets FDA Approval and We’re Profiting Big Time!
May 27, 2009 Small Cap Stock Picks
Its yet another good day to be a Black Service Member ! Our position in ANPI, which we made our first purchase at 1.26 and then again on the dip at 1.15, gained FDA approval and now is exploding on huge volume today and up over 30%.
11:56AM Angiotech Pharm announces FDA approval of next-generation TAXUS Liberte Atom Stent system (ANPI) 1.31 +0.12 : Co announces its corporate partner, Boston Scientific (BSX) has received approval from the FDA to market its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-generation drug-eluting stent specifically designed for treating small coronary vessels. It was approved for use in vessels as small as 2.25 mm in diameter and joins the TAXUS Express Atom Stent as the only drug-eluting stents approved for small vessel use in the U.S. The Company plans to begin a full U.S. launch of TAXUS Liberte Atom next month.
This move marks the breakout of this bullish symmetrical triangle and with the huge volume and FDA news, this is providing us with some huge momentum going forward. I definitely think that it is possible for this stock to hit $2/share
Want to profit with me and the ttt.net Black Service Trading crew??
